A Study to Assess YH003 in Combination with Pebolizumab and Albumin Paclitaxel Injection in Subjects with Unresectable/metastatic Mucosal Melanoma
Clinical trial NCT05420324 · COMPLETED
Trial details
- NCT number
- NCT05420324
- Sponsor
- Eucure (Beijing) Biopharma Co., Ltd
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-06-13
- Primary completion
- 2024-03-04
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.